Did you know that Alphabet Inc (NASDAQ:GOOG, NASDAQ:GOOGL) went skidding into the end of 2017? Some investors may not have noticed the underperformance in Google stock, as it stumbled up to and through the holiday trading periods. On Dec. 18, Alphabet stock leaped to new all-time highs, before d
The recent earning announcement on May 31, 2017 created sudden fear in the public’s mind and brought the stock price of Michael Kors (NYSE:KORS) down by around 9% in one day. As of this writing, the price remains at $33. In this article, I will discuss one negative and five positives, and explain why you should consider buying the stock at this low price.
There has been a lot of chatter over the past few years that Apple should make a more drastic move into the media/entertainment industry. While the company has been nibbling at the edges it made a major move this past week hiring two Sony Pictures Television executives where they have served as presidents since 2005. Jamie Erlicht and Zack Van Amburg have been instrumental in more than tripling....More>>>
Shares ofGoPro (NASDAQ:GPRO) sank to fresh all-time lows on Monday, following an analyst downgrade (via Tech Trader Daily). Goldman Sachs analyst Simona Jankowski dropped her rating on GoPro from neutral to sell, while simultaneously slashing her price target down to a mere $6, or about 30% lower than where shares closed on Friday.
Jankowski lays out a handful of concerns, including saturation....More>>>
Today, a quick review of one of my new favorite themes: "Bizarro Capitalism"… To preview the conclusions, you'll find below there's a hidden downside to global central banks' campaigns of endless credit expansion and zero interest rates: As capital costs disappear, so do profit margins. Equity investors will surely cheer financial innovations that....More>>>
Related USO Technical Breakdown: Watch For A Bottom In Crude Oil & XOP Gadfly's Liam Denning: Disney Movies Are More Exciting Than OPEC Meetings This Top Tech ETF Still In Buy Zone; Gold Plays Shine (Investor’s Business Daily)
The breakthrough therapy designation is generally bestowed upon some of the most innovative and potentially groundbreaking drugs in the pharmaceutical space. Trevena (NASDAQ:TRVN) is not much different with a potentially differentiated Phase III candidate called Oliceridine, which could be a wonderful therapy for the treatment of acute pain. Although the treatment is scientifically compelling, I....More>>>
A pile of rusty pipes and materials are all that remain of Lanzhou New Area’s tram project. Only a year ago it was a flagship public-private partnership for the planned city in Central China, before it fell victim to President Xi Jinping’s debt clampdown.